<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04614090</url>
  </required_header>
  <id_info>
    <org_study_id>Leif Mattisson</org_study_id>
    <nct_id>NCT04614090</nct_id>
  </id_info>
  <brief_title>Fast Reversal of Warfarin and Early Surgery in Patients With Trochanteric Hip Fracture A Case-control Study</brief_title>
  <official_title>Is Fast Reversal and Early Surgery (Within 24 h) in Patients on Warfarin Medication With Trochanteric Hip Fractures Safe: A Case-control Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stockholm South General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska Institutet</source>
  <brief_summary>
    <textblock>
      A retrospective case-control study. To evaluate if early surgery within 24hours of troch or&#xD;
      subtrochanteric hip fractures using intramedullary nailing is safe in patients on warfarin&#xD;
      treatment after fast reversal of the warfarin effect&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2017</start_date>
  <completion_date type="Actual">June 26, 2018</completion_date>
  <primary_completion_date type="Actual">February 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Transfusion rates</measure>
    <time_frame>Pre-surgery</time_frame>
    <description>Hb value (g/dl)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Transfusion rates</measure>
    <time_frame>Pre-surgery</time_frame>
    <description>Transfusion rate (n)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Transfusion rates</measure>
    <time_frame>During the surgery</time_frame>
    <description>Hb value (g/dl)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Transfusion rates</measure>
    <time_frame>During the surgery</time_frame>
    <description>Transfusion rate (n)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Transfusion rates</measure>
    <time_frame>2-4 days after the surgery</time_frame>
    <description>Hb value (g/dl)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Transfusion rates</measure>
    <time_frame>2-4 days after the surgery</time_frame>
    <description>Transfusion rate (n)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>adverse events</measure>
    <time_frame>Immediately after the surgery</time_frame>
    <description>Number of patients with a myocardial infarction, stroke, pulmonary embolism, deep venous thrombosis, sepsis, pneumonia, urinary tract infection, pressure ulcer, or any adverse events.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>Immediately after the surgery</time_frame>
    <description>The number of deaths</description>
  </primary_outcome>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>30-days after the surgery</time_frame>
    <description>The number of deaths</description>
  </primary_outcome>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>1 year after the surgery</time_frame>
    <description>The number of deaths</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">198</enrollment>
  <condition>Trochanteric Hip Fractures</condition>
  <condition>Warfarin Medication</condition>
  <condition>Early Surgery</condition>
  <arm_group>
    <arm_group_label>99 warfarin patients</arm_group_label>
    <description>warfarin patients were operated within 24 h with a cephalomedullary nail due to a trochanteric or subtrochanteric hip fracture. All patients on warfarin were reversed if necessary to INR≤1.5 before surgery using vitamin K and/or four-factor prothrombin complex concentrate (PCC)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>99 patients without anticoagulants</arm_group_label>
    <description>As a 1:1 ratio control group matched for age, gender and surgical implant. All patients were operated within 24 h with a cephalomedullary nail due to a trochanteric or subtrochanteric hip fracture.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients on warfarin, with low-energi trauma, &gt;60years, mean 86 years Op at Stockholm South&#xD;
        General Hospital (södersjukhuset) between (Jan 1,2011 - Dec 31,2014) Follow-up 1 year, all&#xD;
        pat op within 24 hours from hospital arrival to the surgery. Operated with Intramedullary&#xD;
        nail due to unstable intertrochanteric (OTA/AO 31A2, A3) or Subtrochanteric fracture&#xD;
        (OTA/AO 32A,32B,32C).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Exclusion Criteria:&#xD;
&#xD;
          -  Pathological fracture&#xD;
&#xD;
          -  Late presentation to the hospital&#xD;
&#xD;
          -  Other injuries&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Leif Mattisson</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stockholm South General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Södersjukhuset</name>
      <address>
        <city>Stockholm</city>
        <state>Sjukhusbacken 10</state>
        <zip>11883</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <results_reference>
    <citation>Mattisson L, Lapidus LJ, Enocson A. Is fast reversal and early surgery (within 24 h) in patients on warfarin medication with trochanteric hip fractures safe? A case-control study. BMC Musculoskelet Disord. 2018 Jun 26;19(1):203. doi: 10.1186/s12891-018-2126-3.</citation>
    <PMID>29945596</PMID>
  </results_reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 28, 2020</study_first_submitted>
  <study_first_submitted_qc>October 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 3, 2020</study_first_posted>
  <last_update_submitted>October 28, 2020</last_update_submitted>
  <last_update_submitted_qc>October 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Leif Mattisson</investigator_full_name>
    <investigator_title>Senior Consultant Orthopaedic Surgeon MD.,Ph.D.</investigator_title>
  </responsible_party>
  <keyword>Hip fracture</keyword>
  <keyword>Surgical treatment</keyword>
  <keyword>Warfarin</keyword>
  <keyword>Anticoagulation treatment</keyword>
  <keyword>Intramedullary nailing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Hip Fractures</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

